In pancreatic cancer, suppression of ALKBH5 significantly promotes the migration, invasion, and proliferation of pancreatic ductal adenocarcinoma (PDAC) cells both in vitro and in vivo, whereas ALKBH5 overexpression yields the opposite effects. Here, ALKBH5 is linked to pancreatic ductal adenocarcinoma.